Brussels pressured drug regulator to review Pfizer vaccine
Leaked documents show that the European Commission put great pressure on the European Medicines Agency to approve the first Covid-19 vaccine simultaneously with the American …
Covid-19: EU countries spent over €220m stockpiling remdesivir despite lack of effectiveness
The drug’s manufacturer was aware of the negative results of the Solidarity trial before the European Commission struck a procurement deal with it, finds an …
Women not underrepresented in clinical trials
A Dutch advocacy group claims that women receive worse care than men, because pharmaceutical companies do not sufficiently test their medicines on women. A shocking …
‘As long as it is for free’
By Lucien Hordijk & Daan Marselis Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. …
From blockbuster to nichebuster
Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigative Desk, published in …
EMA rewrites medicine approval policy
New innovative medicines should be made available to European citizens more quickly. That is why the European Medicines Agency updates the process for market authorisation. …
Evergreening the world’s most profitable medicine
Even after the expiration of Humira’s patent protection, AbbVie, the pharmaceutical company, almost completely fended off biosimilar competition for this blockbuster medicine in the Netherlands. …
Reconstruction lutetium octreotate
By Lucien Hordijk Steve Jobs’ private plane, parked at Rotterdam Airport. It is September 2008 when local reporters receive tips about the arrival of Apple’s …
